BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16248844)

  • 1. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death.
    LeBlanc AC
    Curr Alzheimer Res; 2005 Oct; 2(4):389-402. PubMed ID: 16248844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
    Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
    EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic slaughter in Alzheimer's disease.
    Coleman PD; Yao PJ
    Neurobiol Aging; 2003 Dec; 24(8):1023-7. PubMed ID: 14643374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain's microenvironment, early functional loss, and the conversion to Alzheimer's disease.
    Cotman CW; Anderson AJ
    Ann N Y Acad Sci; 2000; 924():112-6. PubMed ID: 11193787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular mechanisms of Alzheimer's neurodegeneration.
    Zlokovic BV
    Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion.
    Roth KA
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):829-38. PubMed ID: 11556539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.
    Stadelmann C; Deckwerth TL; Srinivasan A; Bancher C; Brück W; Jellinger K; Lassmann H
    Am J Pathol; 1999 Nov; 155(5):1459-66. PubMed ID: 10550301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration.
    Alberghina L; Colangelo AM
    BMC Neurosci; 2006 Oct; 7 Suppl 1(Suppl 1):S2. PubMed ID: 17118156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease.
    Chan SL; Griffin WS; Mattson MP
    J Neurosci Res; 1999 Aug; 57(3):315-23. PubMed ID: 10412022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.
    Copani A; Guccione S; Giurato L; Caraci F; Calafiore M; Sortino MA; Nicoletti F
    Curr Med Chem; 2008; 15(24):2420-32. PubMed ID: 18855671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease.
    Zilkova M; Koson P; Zilka N
    Bratisl Lek Listy; 2006; 107(9-10):366-73. PubMed ID: 17262989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of apoptosis related proteins in brains of patients with Alzheimer's disease.
    Engidawork E; Gulesserian T; Seidl R; Cairns N; Lubec G
    Neurosci Lett; 2001 May; 303(2):79-82. PubMed ID: 11311497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?
    Dickson DW
    J Clin Invest; 2004 Jul; 114(1):23-7. PubMed ID: 15232608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.